| Neuronal differentiation is triggered by oleic acid synthesized and released by astrocytes A Tabernero, EM Lavado, B Granda, A Velasco, JM Medina Journal of neurochemistry 79 (3), 606-616, 2001 | 126 | 2001 |
| In vitro high affinity α‐synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain1 L Ye, A Velasco, G Fraser, TG Beach, L Sue, T Osredkar, V Libri, ... Journal of neurochemistry 105 (4), 1428-1437, 2008 | 99 | 2008 |
| Transcytosis of albumin in astrocytes activates the sterol regulatory element-binding protein-1, which promotes the synthesis of the neurotrophic factor oleic acid A Tabernero, A Velasco, B Granda, EM Lavado, JM Medina Journal of Biological Chemistry 277 (6), 4240-4246, 2002 | 91 | 2002 |
| The neurotrophic effect of oleic acid includes dendritic differentiation and the expression of the neuronal basic helix‐loop‐helix transcription factor NeuroD2 RA Rodríguez‐Rodríguez, A Tabernero, A Velasco, EM Lavado, ... Journal of neurochemistry 88 (5), 1041-1051, 2004 | 75 | 2004 |
| Megalin is a receptor for albumin in astrocytes and is required for the synthesis of the neurotrophic factor oleic acid A Bento‐Abreu, A Velasco, E Polo‐Hernández, PL Pérez‐Reyes, ... Journal of neurochemistry 106 (3), 1149-1159, 2008 | 74 | 2008 |
| Albumin endocytosis via megalin in astrocytes is caveola‐and Dab‐1 dependent and is required for the synthesis of the neurotrophic factor oleic acid A Bento‐Abreu, A Velasco, E Polo‐Hernández, C Lillo, R Kozyraki, ... Journal of neurochemistry 111 (1), 49-60, 2009 | 64 | 2009 |
| The role of Omega-3 and Omega-9 fatty acids for the treatment of neuropathic pain after neurotrauma I Galán-Arriero, D Serrano-Muñoz, J Gómez-Soriano, C Goicoechea, ... Biochimica et Biophysica Acta (BBA)-Biomembranes 1859 (9), 1629-1635, 2017 | 60 | 2017 |
| Role of oleic acid as a neurotrophic factor is supported in vivo by the expression of GAP-43 subsequent to the activation of SREBP-1 and the up-regulation of stearoyl-CoA … A Velasco, A Tabernero, JM Medina Brain research 977 (1), 103-111, 2003 | 55 | 2003 |
| Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans, trans)-1-fluoro-2, 5-bis (3-hydroxycarbonyl-4-hydroxy) styrylbenzene] A Velasco, G Fraser, P Delobel, B Ghetti, I Lavenir, M Goedert FEBS letters 582 (6), 901-906, 2008 | 50 | 2008 |
| The enhancement of glucose uptake caused by the collapse of gap junction communication is due to an increase in astrocyte proliferation A Tabernero, C Jiménez, A Velasco, C Giaume, JM Medina Journal of neurochemistry 78 (4), 890-898, 2001 | 44 | 2001 |
| ATP‐Sensitive Potassium Channel Regulates Astrocytic Gap Junction Permeability by a Ca2+‐Independent Mechanism A Velasco, A Tabernero, B Granda, JM Medina Journal of neurochemistry 74 (3), 1249-1256, 2000 | 41 | 2000 |
| Endocytosis and transcytosis of amyloid-β peptides by astrocytes: a possible mechanism for amyloid-β clearance in Alzheimer’s disease M Domínguez-Prieto, A Velasco, A Tabernero, JM Medina Journal of Alzheimer's Disease 65 (4), 1109-1124, 2018 | 40 | 2018 |
| Prenatal administration of oleic acid or linolenic acid reduces neuromorphological and cognitive alterations in Ts65dn down syndrome mice S García-Cerro, N Rueda, V Vidal, A Puente, V Campa, S Lantigua, ... The Journal of nutrition 150 (6), 1631-1643, 2020 | 21 | 2020 |
| Aberrant co-localization of synaptic proteins promoted by Alzheimer’s disease amyloid-β peptides: protective effect of human serum albumin M Dominguez-Prieto, A Velasco, L Vega, A Tabernero, JM Medina Journal of Alzheimer's Disease 55 (1), 171-182, 2017 | 19 | 2017 |
| Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome M Hijazi, C Fillat, JM Medina, A Velasco Experimental neurology 239, 229-234, 2013 | 15 | 2013 |
| Restrained phosphatidylcholine synthesis in a cellular model of down’s syndrome is associated with the overexpression of DyRk1A M Hijazi, JM Medina, A Velasco Molecular neurobiology 54, 1092-1100, 2017 | 6 | 2017 |
| Fatty acids and antioxidants in multiple sclerosis: therapeutic role of GEMSP P Ahumada-Pascual, DG Gañán, YEB Montero, A Velasco Current Pharmaceutical Design 25 (4), 376-380, 2019 | 5 | 2019 |
| Recent Advances on Immunosuppressive Drugs and Remyelination Enhancers for the Treatment of Multiple Sclerosis J Cadenas-Fernández, P Ahumada-Pascual, LS Andreu, A Velasco Current Pharmaceutical Design 27 (30), 3273-3280, 2021 | 1 | 2021 |
| Impact of reflex locomotion and the Bobath concept on clinical and biomolecular parameters in people with multiple sclerosis: study protocol for a randomized controlled trial A Abreu-Corrales, A Velasco, A Cuesta-Gómez, JL Sánchez-González Frontiers in Neurology 14, 1209477, 2023 | | 2023 |
| Efecto del factor neurotrófico ácido oleico en modelos celulares de síndrome de Down M Hijazi Vega | | 2014 |
